GlassScriptPhysician profile
Caroline E Lurz
NPI 1316520026
$790.76
in general payments reported to CMS, 2019-2025
12 companies · $222 in 2025
The $222 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.60 · 2023: $231 · 2024: $313 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.81 | 2022-2025 | |
| Leo Pharma INC. | $92.55 | 2024 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $67.39 | 2024 | Sotyktu |
| Janssen Biotech, INC. | $59.99 | 2025 | Tremfya |
| Genzyme Corporation | $59.06 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $52.04 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $50.16 | 2023-2025 | |
| Galderma Laboratories, L.P. | $41.40 | 2023-2025 | Nemluvio |
| Dermavant Sciences, INC. | $37.75 | 2023 | Vtama |
| Glaxosmithkline, LLC. | $24.45 | 2023 | Arexvy, Shingrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.75 | 2024 | Cabtreo |
| Lnhc, INC | $21.41 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Lurz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.